Rajanbhai Amin, MD
Family Medicine · Louisville, KYNPI 1336165943
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $20,543 of the $25,696 with a category attached, or 79.9%. Optos, Inc. accounts for 79.9% of it on its own, with 37 other manufacturers making up the rest. 2025 is the largest year on record at $21,871, more than ten times the $607 reported in 2019. Among family medicine clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 213 payments — averaging $120.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Optos, Inc.$21K
- AbbVie$787
- Amgen$468
- Pfizer$463
- Bayer$344
- GSK$311
- plus $3K from 32 others
What the payments were for
- Speaking & faculty fees$20,54380%
- Food & beverage$5,13320%
- Education$200%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Optos, Inc. | 1 | $20,543 |
| AbbVie | 56 | $787 |
| Amgen | 13 | $468 |
| Pfizer | 25 | $463 |
| Bayer | 8 | $344 |
| GSK | 6 | $311 |
| Vanda Pharmaceuticals Inc. | 15 | $263 |
| Novartis | 16 | $240 |
| Abbott | 5 | $238 |
| Johnson & Johnson | 3 | $211 |
| Sunovion Pharmaceuticals Inc. | 5 | $189 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 12 | $187 |
| Indivior Inc. | 1 | $173 |
| Sirtex Medical Inc | 1 | $140 |
| Exact Sciences | 6 | $129 |
| Esperion Therapeutics, Inc. | 1 | $122 |
| Silk Road Medical, Inc. | 1 | $105 |
| Sanofi | 1 | $100 |
| Hologic Sales And Service, LLC | 5 | $73 |
| Protega Pharmaceutials Inc | 1 | $67 |
| Astellas Pharma US Inc | 3 | $67 |
| Novo Nordisk | 3 | $64 |
| Merck | 3 | $47 |
| AstraZeneca | 3 | $46 |
| Dexcom, Inc. | 2 | $40 |
| Ultragenyx Pharmaceutical Inc. | 2 | $39 |
| Axsome Therapeutics, Inc. | 2 | $33 |
| Medtronic | 1 | $28 |
| Seqirus USA Inc | 2 | $26 |
| Lilly USA, LLC | 2 | $25 |
| Evoke Pharma, Inc. | 1 | $21 |
| Alnylam Pharmaceuticals Inc. | 1 | $20 |
| Eisai Inc. | 1 | $18 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $17 |
| Shield Therapeutics Inc | 1 | $15 |
| Shire North American Group Inc | 1 | $15 |
| Global Blood Therapeutics, Inc. | 1 | $12 |
| Mylan Specialty L.p. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AREXVY$248
- Kerendia$241
- PERSERIS$173
- CardioMEMS HF System$144
- SIR-Spheres Microspheres$140
- LONHALA MAGNAIR$123
- ELIQUIS$122
- NEXLIZET$122
- NEXLETOL$122
- Repatha$115
- UBRELVY$112
- ENROUTE Transcarotid Neuroprotection System$105
- ENHANCE Transcarotid Peripheral Access Kit$105
- ENROUTE Transcarotid Stent$105
- ENROUTE .014 Guidewire$105
How this compares
$25,696 in reported general payments places this provider in the 95th percentile of 1,559 family medicine providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 53 | $68,216 |
| OzempicSemaglutide | 62 | $65,071 |
| EliquisApixaban | 50 | $39,132 |
| LinzessLinaclotide | 37 | $31,500 |
| FarxigaDapagliflozin Propanediol | 32 | $28,086 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 26 | $21,750 |
| JanuviaSitagliptin Phosphate | 16 | $21,642 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 469 | $17,366 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 528 | $16,200 |
| XareltoRivaroxaban | 11 | $15,892 |
| JardianceEmpagliflozin | 11 | $15,056 |
| SymbicortBudesonide/Formoterol Fumarate | 43 | $13,491 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 25 | $12,700 |
| Oxycodone Hcl | 362 | $9,895 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 12 | $9,596 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $64 | $65,07162 claims |
| AstraZenecaFarxiga, Symbicort | $46 | $41,57875 claims |
| PfizerEliquis | $463 | $39,13250 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $311 | $34,44951 claims |
| AbbVieLinzess | $787 | $31,50037 claims |
| MerckJanuvia | $47 | $21,64216 claims |
| Johnson & JohnsonXarelto | $211 | $15,89211 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,559 family medicine providers in Kentucky.
Other family medicine in Louisville
- Christopher RhyneLouisville$933K
- Suraj GathaniLouisville$69K
- Mandy WhittLouisville$38K
- Michael PendletonLouisville$29K
- James WrightLouisville$18K
- Rosenberg ReyesLouisville$18K
- Dennis GrayLouisville$14K
- Vincent LangLouisville$12K
- Jaivanti LohanoLouisville$11K
- John RichardLexington$226K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.